Chair
    1.
    发明授权
    Chair 失效
    椅子

    公开(公告)号:US07350869B2

    公开(公告)日:2008-04-01

    申请号:US10563006

    申请日:2004-06-22

    CPC classification number: A47C7/20 A47C7/029

    Abstract: A chair (1), including a seat (5), wherein the seat (5) includes a barrier zone (10) dividing said seat (5) into a front seat portion (15) and a rear seat portion (20), said rear seat portion (20) being of a material more easily deformed than said barrier zone (10), such that in use, movement of the user's buttocks from said rear seat portion (20) towards said front seat portion (15) urges the rear seat portion (20) towards said barrier zone (10), deforming said rear seat portion (20) and inhibiting said buttocks from moving towards said front seat portion (15).

    Abstract translation: 一种包括座椅(5)的椅子(1),其中所述座椅(5)包括将所述座椅(5)分成前座椅部分(15)和后座椅部分(20)的阻挡区域(10),所述座椅 后座部分(20)是比所述阻挡区(10)更容易变形的材料,使得在使用中,使用者的臀部从所述后座部分(20)向所述前座部分(15)的移动促使后座 座部分(20)朝向所述阻挡区域(10),使所述后座部分(20)变形并且阻止所述臀部向所述前座部分(15)移动。

    Interleukin-10 compositions for the treatment of adenocarcinomas
    4.
    发明申请
    Interleukin-10 compositions for the treatment of adenocarcinomas 有权
    用于治疗腺癌的白细胞介素-10组合物

    公开(公告)号:US20070122383A1

    公开(公告)日:2007-05-31

    申请号:US11598002

    申请日:2006-11-13

    CPC classification number: A61K38/2066

    Abstract: The present invention is directed to methods for the treatment of adenocarcinomas that are characterized by the overexpression of a particular oncogene, Pim-1. The procedure involves administering a therapeutically effective amount of interleukin-10 that has been coupled to a carrier that increases its circulating plasma half-life.

    Abstract translation: 本发明涉及用于治疗腺癌的方法,其特征在于过表达特定致癌基因Pim-1。 该方法包括施用治疗有效量的已经偶联于载体的白细胞介素-10,其增加其循环血浆半衰期。

Patent Agency Ranking